Trades on 1 secondary market

Octant

Octant is a precision medicine company developing next-generation small molecule therapeutics by merging biology, chemistry, and computation to engineer drugs that target complex cellular mechanisms. Its programs span protein misfolding and mistrafficking diseases, oncology, metabolism, and immunolo

minimal 11.2 / 100 0 APIs View provider profile →

Company Biotechnology Precision Medicine Drug Discovery Therapeutics Life Sciences

Octant is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.